Adverum Biotechnologies, Inc.(ADVM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADVM Adverum Biotechnologies, Inc.

停牌 12-12 16:00:00 EST

4.36

+0.00

0.00%

最高4.36	最低4.36	成交量0.00
今开4.36	昨收4.36	日振幅0.00%
总市值9,626万	流通市值4,954万	总股本2,208万
成交额0.00	换手率0.00%	流通股本1,136万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADVM","market":"US","secType":"STK","nameCN":"Adverum Biotechnologies, Inc.","latestPrice":4.36,"timestamp":1765573200000,"preClose":4.36,"halted":3,"volume":0,"delay":0,"floatShares":11362749,"shares":22077467,"eps":-8.5585,"marketStatus":"停牌","change":0,"latestTime":"12-12 16:00:00 EST","open":4.36,"high":4.36,"low":4.36,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.5585,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.36,"volumeRatio":0},"requestUrl":"/m/hq/s/ADVM","defaultTab":"news","newsList":[{"id":"1109822769","title":"Adverum Biotechnologies Inc：收购要约计划于2025年12月8日东部时间晚上11:59过后一分钟到期","url":"https://stock-news.laohu8.com/highlight/detail?id=1109822769","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109822769?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:02","pubTimestamp":1764590529,"startTime":"0","endTime":"0","summary":"Adverum Biotechnologies Inc：收购要约计划于2025年12月8日东部时间晚上11:59过后一分钟到期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU2265009873.SGD","LU0353189680.USD","IE0004445239.USD","LU2746668974.SGD","BK4007","LU0323591593.USD","LU1868836914.USD","LU1623119135.USD","LU0097036916.USD","LU0456855351.SGD","LU0820561909.HKD","LU2168564222.USD","SG9999018865.SGD","LU0106261372.USD","LU1061106388.HKD","LU2108987350.USD","IE00BFTCPJ56.SGD","LU0353189763.USD","LU2168564495.EUR","LU0943347566.SGD","SG9999014906.USD","LU1069344957.HKD","LU2746668461.USD","LU1868836757.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU1868836591.USD","LU0471298694.HKD","LU1551013425.SGD","LU0882574139.USD","SG9999015945.SGD","LU2237443549.SGD","LU2324357040.USD","BK4516","LU1280957306.USD","LU2168564149.EUR","LU2211815571.USD","LU1093756325.SGD","LU0079474960.USD","LU1035775433.USD","LU1974910355.USD","LU0820561818.USD","LU2471134523.USD","LLY","LU0203201768.USD","BK4588","LU0256863902.USD","LU1720051108.HKD","SG9999014898.SGD","SG9999015952.SGD","SG9999015978.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","GB00BDT5M118.USD","LU0640476718.USD","SGXZ31699556.SGD","LU2237443465.HKD","LU0006306889.USD","LU1548497426.USD","LU0238689110.USD","LU2491050154.USD","BK4139","BK4533","LU1232071149.USD","LU1127390331.HKD","LU2264538146.SGD","LU2552382132.HKD","LU2602419157.SGD","LU2361044865.SGD","LU2750360997.AUD","LU1267930730.SGD","IE00B1BXHZ80.USD","ADVM","IE00BJLML261.HKD","LU0256863811.USD","LU2462157665.USD","SG9999014880.SGD","LU2168563687.JPY","LU2023250504.SGD","LU2361045086.USD","LU0882574055.USD","LU1983299246.USD","LU2089984988.USD","SG9999013999.USD","LU0114720955.EUR","LU2237443895.HKD","LU1868837300.USD","IE0009355771.USD","SGXZ57979304.SGD","LU2361044949.HKD","IE00BKPKM429.USD","LU2237443382.USD","LU0823434740.USD","IE00BWXC8680.SGD","LU2357305700.SGD","IE00BKDWB100.SGD","SG9999017495.SGD","SGXZ51526630.SGD","LU1988902786.USD","LU0354030438.USD","LU1720051017.SGD","LU0889565916.HKD","LU0061475181.USD","LU0320765059.SGD","LU2417539215.USD","LU2552382215.SGD","LU2552382058.USD","LU0354030511.USD","LU0432979614.USD","LU0823416689.USD","IE00B4R5TH58.HKD","LU1323610961.USD","LU2087625088.SGD","LU0786609619.USD","BK4581","LU0385154629.USD","LU2471134952.CNY","LU2750360641.GBP","LU1804176565.USD","LU0471298777.SGD","LU0466842654.USD","IE00BK4W5M84.HKD","BK4534","SG9999001176.SGD","LU2468319806.SGD","LU1712237335.SGD","IE00B1XK9C88.USD","LU2471134879.HKD","LU1814569148.SGD","LU0198837287.USD","LU0234572021.USD","LU1023059063.AUD","LU2168564065.EUR","SG9999018857.SGD","LU2471134796.USD","LU1093756168.USD","LU1551013342.USD","LU0289739699.SGD","LU0689472784.USD","SG9999015986.USD","LU0109391861.USD","LU1064131342.USD","LU2063271972.USD","IE0002141913.USD","BK4599","LU0109394709.USD","LU0417517546.SGD","LU0122379950.USD","LU0672654240.SGD","LU1291159041.SGD","LU2106854487.HKD","LU2237438978.USD","SG9999001176.USD","LU0266013472.USD","LU2491050071.SGD","LU0708995401.HKD","LU1917777945.USD","LU2236285917.USD","IE00B2B36J28.USD","BK4585","LU0316494557.USD","LU0823434583.USD","LU2237443978.SGD","SG9999014914.USD","SGXZ81514606.USD","LU1366192091.USD","LU0094547139.USD","IE00BK4W5L77.USD","LU1868837136.USD","LU1989771016.USD","LU0203202063.USD","LU2360106947.USD","LU2237443622.USD","LU2456880835.USD","LU2461242641.AUD","LU2491049909.HKD","LU0058720904.USD","SGXZ99366536.SGD"],"gpt_icon":0},{"id":"1151767919","title":"Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc终止与Adverum Biotechnologies签署的2021年1月8日特定租赁协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1151767919","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151767919?lang=zh_cn&edition=full","pubTime":"2025-11-22 05:04","pubTimestamp":1763759055,"startTime":"0","endTime":"0","summary":"Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc终止与Adverum Biotechnologies签署的2021年1月8日特定租赁协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2577511046","title":"基因治疗公司Adverum(ADVM.US)盘前跳涨！获礼来(LLY.US)收购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2577511046","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577511046?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:23","pubTimestamp":1761312180,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，制药巨头礼来周五公布了收购基因治疗公司Adverum Biotechnologies及其主要基因治疗候选药物Ixo-vec的计划。受此消息提振，Adverum周五美股盘前一度涨近29%，截至发稿涨幅缩窄至逾6%。根据协议，礼来将发起收购要约，以每股3.56美元的价格收购所有已发行的Adverum股票。礼来表示，此次收购将结合其基因药物研发能力与Adverum在眼科基因疗法领域的技术优势，有助于拓展基因疗法在减轻年龄相关疾病负担方面的潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0de6a0a50611a781da668f8b53e018c2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2746668461.USD","LLY","LU0266013472.USD","LU0106261372.USD","SG9999015945.SGD","LU1868836914.USD","LU0122379950.USD","LU0672654240.SGD","IE0009355771.USD","SG9999015986.USD","LU0471298777.SGD","ADVM","LU1069344957.HKD","SG9999001176.SGD","LU0823434740.USD","LU0006306889.USD","SG9999018857.SGD","LU2087625088.SGD","LU1551013425.SGD","SG9999017495.SGD","LU1057294990.SGD","BK4599","SG9999013999.USD","LU1868836757.USD","LU1868837136.USD","LU0354030511.USD","LU2264538146.SGD","LU1868837300.USD","LU0203202063.USD","SGXZ99366536.SGD","LU1061106388.HKD","LU1983299246.USD","LU2750360997.AUD","BK4007","SG9999001176.USD","SG9999015952.SGD","IE0002141913.USD","LU1720051108.HKD","LU1868836591.USD","SG9999014906.USD","SGXZ51526630.SGD","LU1548497426.USD","SG9999014898.SGD","LU1035775433.USD","SG9999018865.SGD","LU2106854487.HKD","LU0114720955.EUR","LU0354030438.USD","LU1814569148.SGD","LU1291159041.SGD"],"gpt_icon":1},{"id":"1134457465","title":"盘前异动","url":"https://stock-news.laohu8.com/highlight/detail?id=1134457465","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134457465?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:00","pubTimestamp":1761310850,"startTime":"0","endTime":"0","summary":"礼来宣布将收购该公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVM"],"gpt_icon":0},{"id":"2575496207","title":"Adverum Biotechnologies, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575496207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575496207?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:49","pubTimestamp":1760449785,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日21时49分，Adverum Biotechnologies, Inc.股票出现波动，股价急速上涨5.05%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Genprex, Inc.涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为2302.61%、21.89%、17.62%，振幅较大的相关个股有Pmgc Holdings Inc.、Genprex, Inc.、Bio Green Med Solution, Inc.，振幅分别为40.31%、25.72%、21.16%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014214945972da01b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014214945972da01b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2572765750","title":"Adverum Biotechnologies, Inc.盘中异动 临近收盘快速拉升5.28%报5.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572765750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572765750?lang=zh_cn&edition=full","pubTime":"2025-10-04 03:30","pubTimestamp":1759519805,"startTime":"0","endTime":"0","summary":"北京时间2025年10月04日03时30分，Adverum Biotechnologies, Inc.股票出现异动，股价大幅上涨5.28%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Alto Neuroscience, Inc.、Neuphoria Therapeutics Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Alto Neuroscience, Inc.、Palisade Bio, Inc.、Ovid Therapeutics Inc.较为活跃，换手率分别为217.13%、195.92%、76.06%，振幅较大的相关个股有Alto Neuroscience, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Leap Therapeutics, Inc.，振幅分别为84.58%、48.83%、46.01%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251004033006a6ac5c42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251004033006a6ac5c42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"1155399000","title":"Adverum Biotechnologies宣布完成Ixo-Vec治疗湿性年龄相关性黄斑变性关键性三期Artemis试验的患者筛选","url":"https://stock-news.laohu8.com/highlight/detail?id=1155399000","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155399000?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:00","pubTimestamp":1758542438,"startTime":"0","endTime":"0","summary":"Adverum Biotechnologies, Inc.宣布，已完成针对湿性年龄相关性黄斑变性的Ixo-Vec疗法关键性三期Artemis试验的患者筛选工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2564316653","title":"Adverum Biotechnologies, Inc.盘中异动 股价大涨5.26%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564316653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564316653?lang=zh_cn&edition=full","pubTime":"2025-09-03 21:54","pubTimestamp":1756907655,"startTime":"0","endTime":"0","summary":"北京时间2025年09月03日21时54分，Adverum Biotechnologies, Inc.股票出现异动，股价急速上涨5.26%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Yd Bio Limited、Yd Bio Ltd C/Wts 28/08/2030涨幅较大，Promis Neurosciences Inc.、Novabay Pharmaceuticals, Inc.、Artelo Biosciences, Inc.较为活跃，换手率分别为78.98%、41.11%、22.29%，振幅较大的相关个股有Yd Bio Limited、Kalaris Therapeutics, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为32.23%、25.50%、25.00%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903215416a70dbddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903215416a70dbddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2558347574","title":"Adverum Biotechnologies, Inc.盘中异动 急速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558347574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558347574?lang=zh_cn&edition=full","pubTime":"2025-08-09 03:27","pubTimestamp":1754681257,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日03时27分，Adverum Biotechnologies, Inc.股票出现波动，股价快速下跌5.31%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为1.13%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Hyperion Defi, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为687.77%、195.45%、106.99%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Longeveron Inc.，振幅分别为75.81%、73.00%、50.16%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809032738973c6e71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809032738973c6e71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2556651387","title":"Adverum Biotechnologies, Inc.盘中异动 大幅拉升7.40%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556651387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556651387?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:33","pubTimestamp":1754314437,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时33分，Adverum Biotechnologies, Inc.股票出现异动，股价大幅上涨7.40%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Soligenix, Inc.涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2405.02%、853.00%、401.58%，振幅较大的相关个股有Psyence Biomedical Ltd.、Soligenix, Inc.、凯信远达，振幅分别为29.45%、20.98%、15.35%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421335894cee852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421335894cee852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2556814302","title":"Adverum Biotechnologies, Inc.盘中异动 早盘快速下跌5.02%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556814302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556814302?lang=zh_cn&edition=full","pubTime":"2025-08-01 22:02","pubTimestamp":1754056940,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时02分，Adverum Biotechnologies, Inc.股票出现波动，股价快速下挫5.02%。截至发稿，该股报2.27美元/股，成交量5.2673万股，换手率0.25%，振幅5.02%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220220a46fee35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220220a46fee35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2555839330","title":"Adverum Biotechnologies, Inc.盘中异动 股价大涨5.46%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555839330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555839330?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:51","pubTimestamp":1753969902,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时51分，Adverum Biotechnologies, Inc.股票出现波动，股价快速上涨5.46%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为2.04%。其相关个股中，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Psyence Biomedical Ltd.、Soligenix, Inc.较为活跃，换手率分别为4025.80%、3094.10%、2527.82%，振幅较大的相关个股有Soligenix, Inc.、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为49.60%、42.41%、33.00%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215142972a57b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215142972a57b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2555005046","title":"Adverum Biotechnologies, Inc.盘中异动 早盘股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555005046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555005046?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:21","pubTimestamp":1753802508,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时21分，Adverum Biotechnologies, Inc.股票出现异动，股价急速下跌5.85%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Calidi Biotherapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5253.04%、3208.80%、1612.40%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为128.04%、111.54%、75.60%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292321499725af2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292321499725af2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2552127242","title":"Adverum Biotechnologies, Inc.盘中异动 急速上涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552127242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552127242?lang=zh_cn&edition=full","pubTime":"2025-07-17 01:55","pubTimestamp":1752688546,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日01时55分，Adverum Biotechnologies, Inc.股票出现异动，股价快速拉升5.70%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，知临集团、Barinthus Biotherapeutics Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Qualigen Therapeutics, Inc.、知临集团、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为2837.72%、2256.85%、1154.29%，振幅较大的相关个股有知临集团、Barinthus Biotherapeutics Plc、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为334.61%、188.24%、77.54%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717015547a44f35b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717015547a44f35b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2551138691","title":"Adverum Biotechnologies, Inc.盘中异动 快速拉升5.51%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551138691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551138691?lang=zh_cn&edition=full","pubTime":"2025-07-15 01:12","pubTimestamp":1752513146,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日01时12分，Adverum Biotechnologies, Inc.股票出现异动，股价大幅拉升5.51%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为2071.21%、1245.05%、716.49%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Promis Neurosciences Inc.、Dare Bioscience, Inc.，振幅分别为217.02%、210.04%、206.36%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715011227a6a93f5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715011227a6a93f5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2550849621","title":"Adverum Biotechnologies, Inc.盘中异动 急速拉升5.51%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550849621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550849621?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:41","pubTimestamp":1752158488,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日22时41分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅拉升5.51%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Q32 Bio Inc.、Cognition Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃，换手率分别为331.67%、143.36%、99.72%，振幅较大的相关个股有Cognition Therapeutics, Inc.、Neonc Technologies Holdings, Inc.、Q32 Bio Inc.，振幅分别为73.27%、50.34%、50.33%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710224128a6a1db7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710224128a6a1db7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2549552939","title":"Adverum Biotechnologies, Inc.盘中异动 股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549552939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549552939?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:13","pubTimestamp":1751987607,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日23时13分，Adverum Biotechnologies, Inc.股票出现异动，股价急速拉升5.79%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Zyversa Therapeutics, Inc.、Rallybio Corporation、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为1280.05%、544.22%、278.73%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Moleculin Biotech, Inc.，振幅分别为70.96%、70.58%、69.44%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708231327953afd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708231327953afd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2548885098","title":"Adverum Biotechnologies, Inc.盘中异动 快速拉升5.12%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548885098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548885098?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:18","pubTimestamp":1751386736,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时18分，Adverum Biotechnologies, Inc.股票出现异动，股价大幅拉升5.12%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。其相关个股中，Neurogene Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1907.86%、1415.55%、207.57%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为69.61%、55.78%、48.00%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001856a4c95625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001856a4c95625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2547097393","title":"Adverum Biotechnologies, Inc.盘中异动 大幅上涨5.17%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097393?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:32","pubTimestamp":1751290335,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时32分，Adverum Biotechnologies, Inc.股票出现波动，股价急速上涨5.17%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2079.66%、113.39%、60.06%，振幅较大的相关个股有Artelo Biosciences, Inc.、Exicure, Inc.、Eyenovia, Inc.，振幅分别为43.74%、16.13%、14.52%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213216a7264320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213216a7264320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2546729692","title":"Adverum Biotechnologies, Inc.盘中异动 临近收盘快速跳水7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729692?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:50","pubTimestamp":1751053813,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅跳水7.23%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。该信息摘要如下：瑞穗银行：维持Adverum Biotechnologies评级，由优于大市调整至优于大市评级, 目标价由16.00美元调整至12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035013a4c1ca8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035013a4c1ca8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adverum.com","stockEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":0.014},{"period":"3month","weight":0.4437},{"period":"6month","weight":0.7724},{"period":"1year","weight":-0.2378},{"period":"ytd","weight":-0.0664}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adverum Biotechnologies, Inc.于2006年7月17号在特拉华州成立。该公司是一家临床阶段基因治疗公司，针对严重罕见和眼部疾病未满足的医疗需求。 利用他们的下一代腺相关病毒（“AAV”）为基础的定向进化平台，他们生成基因治疗产品的候选人，旨在通过诱导治疗性蛋白质的持续表达来提供持久的功效。 他们的核心能力包括临床开发和内部制造专业知识，特别是在工艺开发，检测开发和现行良好生产规范（“cGMP”）质量控制方面。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.160995},{"month":2,"riseRate":0.666667,"avgChangeRate":0.149283},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.074626},{"month":4,"riseRate":0.555556,"avgChangeRate":-0.076068},{"month":5,"riseRate":0.333333,"avgChangeRate":0.109374},{"month":6,"riseRate":0.5,"avgChangeRate":0.019908},{"month":7,"riseRate":0.7,"avgChangeRate":0.041293},{"month":8,"riseRate":0.4,"avgChangeRate":0.00694},{"month":9,"riseRate":0.4,"avgChangeRate":-0.030043},{"month":10,"riseRate":0.4,"avgChangeRate":-0.07621},{"month":11,"riseRate":0.2,"avgChangeRate":-0.018245},{"month":12,"riseRate":0.5,"avgChangeRate":-0.053493}],"exchange":"NASDAQ","name":"Adverum Biotechnologies, Inc.","nameEN":"Adverum Biotechnologies"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adverum Biotechnologies, Inc.(ADVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adverum Biotechnologies, Inc.(ADVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adverum Biotechnologies, Inc.,ADVM,Adverum Biotechnologies, Inc.股票,Adverum Biotechnologies, Inc.股票老虎,Adverum Biotechnologies, Inc.股票老虎国际,Adverum Biotechnologies, Inc.行情,Adverum Biotechnologies, Inc.股票行情,Adverum Biotechnologies, Inc.股价,Adverum Biotechnologies, Inc.股市,Adverum Biotechnologies, Inc.股票价格,Adverum Biotechnologies, Inc.股票交易,Adverum Biotechnologies, Inc.股票购买,Adverum Biotechnologies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adverum Biotechnologies, Inc.(ADVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adverum Biotechnologies, Inc.(ADVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}